Loading…

The effect of prophylactic treatment with Shohl's solution in children with cystinuria

Abstract Objective To investigate the effect of prophylactic treatment with Shohl's solution on the rates of stone recurrence in paediatric patients with cystinuria. Patients and methods Between June 2007 and October 2011, 185 patients aged 16 years and younger whose stones had been completely...

Full description

Saved in:
Bibliographic Details
Published in:Journal of pediatric urology 2013-12, Vol.9 (6), p.1218-1222
Main Authors: Izol, Volkan, Aridogan, Ibrahim Atilla, Karsli, Onur, Deger, Mutlu, Satar, Nihat
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c417t-ef1fb5446148b220ceaba53379467f707b1c863a5f27ab4c4703779accd50a723
cites cdi_FETCH-LOGICAL-c417t-ef1fb5446148b220ceaba53379467f707b1c863a5f27ab4c4703779accd50a723
container_end_page 1222
container_issue 6
container_start_page 1218
container_title Journal of pediatric urology
container_volume 9
creator Izol, Volkan
Aridogan, Ibrahim Atilla
Karsli, Onur
Deger, Mutlu
Satar, Nihat
description Abstract Objective To investigate the effect of prophylactic treatment with Shohl's solution on the rates of stone recurrence in paediatric patients with cystinuria. Patients and methods Between June 2007 and October 2011, 185 patients aged 16 years and younger whose stones had been completely removed by percutaneous nephrolithotomy (PCNL) were assessed for metabolic risk factors. Seventeen (9%) patients with positive cyanide-nitroprusside tests (CNT) and cystine stones enrolled in this study, and a Shohl's solution was used for alkalinisation. The patients were followed up for a mean period of two years for stone recurrence. Results Of the patients, 10 (59%) were male, and 7 (41%) were female ( p  = 0.13). Twelve patients (70.5%) continued to receive medical prophylaxis regularly, whereas 5 (29.5%) patients did not. The mean pre-treatment and post-treatment urinary pH values were 5.8 ± 0.5 (5–7) and 7.5 ± 0.4 (6.5–8), respectively ( p  
doi_str_mv 10.1016/j.jpurol.2013.05.017
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1462187290</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S1477513113001502</els_id><sourcerecordid>1462187290</sourcerecordid><originalsourceid>FETCH-LOGICAL-c417t-ef1fb5446148b220ceaba53379467f707b1c863a5f27ab4c4703779accd50a723</originalsourceid><addsrcrecordid>eNqFkbuO1TAQQCMEYpeFP0AoHTQJ40fipEFCK17SShS70FqOM1YcfO2L7Sy6f4-vslDQUM0UZ15nquolgZYA6d-u7XrcYnAtBcJa6Fog4lF1SQbBGj6Mw-OScyGajjByUT1LaQVgAuj4tLqgbICeiuGy-n63YI3GoM51MPUxhuNyckpnq-scUeUD-lz_snmpb5ewuNepTsFt2QZfW1_rxbo5ot8JfUrZ-i1a9bx6YpRL-OIhXlXfPn64u_7c3Hz99OX6_U2jORG5QUPM1HHeEz5MlIJGNamOMTHyXhgBYiJ66JnqDBVq4pqLcoIYldZzB0pQdlW92fuWxX9umLI82KTROeUxbEkS3tNihI5QUL6jOoaUIhp5jPag4kkSkGejcpW7UXk2KqGTxWgpe_UwYZsOOP8t-qOwAO92AMud9xajTNqi1zjbWKzKOdj_Tfi3gXbWW63cDzxhWsMWfXEoiUxUgrw9f_X8VMIASAeU_QaJm56q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1462187290</pqid></control><display><type>article</type><title>The effect of prophylactic treatment with Shohl's solution in children with cystinuria</title><source>ScienceDirect Journals</source><creator>Izol, Volkan ; Aridogan, Ibrahim Atilla ; Karsli, Onur ; Deger, Mutlu ; Satar, Nihat</creator><creatorcontrib>Izol, Volkan ; Aridogan, Ibrahim Atilla ; Karsli, Onur ; Deger, Mutlu ; Satar, Nihat</creatorcontrib><description>Abstract Objective To investigate the effect of prophylactic treatment with Shohl's solution on the rates of stone recurrence in paediatric patients with cystinuria. Patients and methods Between June 2007 and October 2011, 185 patients aged 16 years and younger whose stones had been completely removed by percutaneous nephrolithotomy (PCNL) were assessed for metabolic risk factors. Seventeen (9%) patients with positive cyanide-nitroprusside tests (CNT) and cystine stones enrolled in this study, and a Shohl's solution was used for alkalinisation. The patients were followed up for a mean period of two years for stone recurrence. Results Of the patients, 10 (59%) were male, and 7 (41%) were female ( p  = 0.13). Twelve patients (70.5%) continued to receive medical prophylaxis regularly, whereas 5 (29.5%) patients did not. The mean pre-treatment and post-treatment urinary pH values were 5.8 ± 0.5 (5–7) and 7.5 ± 0.4 (6.5–8), respectively ( p  &lt; 0.001). The pre-treatment and post-treatment specific gravities of the urine were 1021.5 ± 5.4 (1010–1030) and 1006 ± 2.3 (1004–1015), respectively ( p  &lt; 0.001). The rates of recurrence were 16.6% among those who continued prophylaxis and 100% among those who did not receive prophylaxis ( p  = 0.001). The most common combination of metabolic anomalies was cystinuria and hypocitraturia ( p  &lt; 0.001). Conclusions This study demonstrated that detailed clinical and laboratory evaluations should be performed for all children with cystine stone disease, and, appropriate prophylactic treatment should be recommended to prevent the reformation of stones.</description><identifier>ISSN: 1477-5131</identifier><identifier>EISSN: 1873-4898</identifier><identifier>DOI: 10.1016/j.jpurol.2013.05.017</identifier><identifier>PMID: 23806278</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Adolescent ; Child ; Child, Preschool ; Children ; Citric Acid - therapeutic use ; Cystinuria ; Cystinuria - drug therapy ; Cystinuria - epidemiology ; Female ; Follow-Up Studies ; Humans ; Hydrogen-Ion Concentration ; Infant ; Male ; Nephrostomy, Percutaneous ; Pediatrics ; Potassium Citrate - therapeutic use ; Recurrence ; Risk Factors ; Secondary Prevention ; Shohl's solution ; Solutions - therapeutic use ; Urolithiasis ; Urolithiasis - drug therapy ; Urolithiasis - epidemiology ; Urolithiasis - prevention &amp; control ; Urology</subject><ispartof>Journal of pediatric urology, 2013-12, Vol.9 (6), p.1218-1222</ispartof><rights>Journal of Pediatric Urology Company</rights><rights>2013 Journal of Pediatric Urology Company</rights><rights>Copyright © 2013 Journal of Pediatric Urology Company. Published by Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c417t-ef1fb5446148b220ceaba53379467f707b1c863a5f27ab4c4703779accd50a723</citedby><cites>FETCH-LOGICAL-c417t-ef1fb5446148b220ceaba53379467f707b1c863a5f27ab4c4703779accd50a723</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23806278$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Izol, Volkan</creatorcontrib><creatorcontrib>Aridogan, Ibrahim Atilla</creatorcontrib><creatorcontrib>Karsli, Onur</creatorcontrib><creatorcontrib>Deger, Mutlu</creatorcontrib><creatorcontrib>Satar, Nihat</creatorcontrib><title>The effect of prophylactic treatment with Shohl's solution in children with cystinuria</title><title>Journal of pediatric urology</title><addtitle>J Pediatr Urol</addtitle><description>Abstract Objective To investigate the effect of prophylactic treatment with Shohl's solution on the rates of stone recurrence in paediatric patients with cystinuria. Patients and methods Between June 2007 and October 2011, 185 patients aged 16 years and younger whose stones had been completely removed by percutaneous nephrolithotomy (PCNL) were assessed for metabolic risk factors. Seventeen (9%) patients with positive cyanide-nitroprusside tests (CNT) and cystine stones enrolled in this study, and a Shohl's solution was used for alkalinisation. The patients were followed up for a mean period of two years for stone recurrence. Results Of the patients, 10 (59%) were male, and 7 (41%) were female ( p  = 0.13). Twelve patients (70.5%) continued to receive medical prophylaxis regularly, whereas 5 (29.5%) patients did not. The mean pre-treatment and post-treatment urinary pH values were 5.8 ± 0.5 (5–7) and 7.5 ± 0.4 (6.5–8), respectively ( p  &lt; 0.001). The pre-treatment and post-treatment specific gravities of the urine were 1021.5 ± 5.4 (1010–1030) and 1006 ± 2.3 (1004–1015), respectively ( p  &lt; 0.001). The rates of recurrence were 16.6% among those who continued prophylaxis and 100% among those who did not receive prophylaxis ( p  = 0.001). The most common combination of metabolic anomalies was cystinuria and hypocitraturia ( p  &lt; 0.001). Conclusions This study demonstrated that detailed clinical and laboratory evaluations should be performed for all children with cystine stone disease, and, appropriate prophylactic treatment should be recommended to prevent the reformation of stones.</description><subject>Adolescent</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Children</subject><subject>Citric Acid - therapeutic use</subject><subject>Cystinuria</subject><subject>Cystinuria - drug therapy</subject><subject>Cystinuria - epidemiology</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Humans</subject><subject>Hydrogen-Ion Concentration</subject><subject>Infant</subject><subject>Male</subject><subject>Nephrostomy, Percutaneous</subject><subject>Pediatrics</subject><subject>Potassium Citrate - therapeutic use</subject><subject>Recurrence</subject><subject>Risk Factors</subject><subject>Secondary Prevention</subject><subject>Shohl's solution</subject><subject>Solutions - therapeutic use</subject><subject>Urolithiasis</subject><subject>Urolithiasis - drug therapy</subject><subject>Urolithiasis - epidemiology</subject><subject>Urolithiasis - prevention &amp; control</subject><subject>Urology</subject><issn>1477-5131</issn><issn>1873-4898</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><recordid>eNqFkbuO1TAQQCMEYpeFP0AoHTQJ40fipEFCK17SShS70FqOM1YcfO2L7Sy6f4-vslDQUM0UZ15nquolgZYA6d-u7XrcYnAtBcJa6Fog4lF1SQbBGj6Mw-OScyGajjByUT1LaQVgAuj4tLqgbICeiuGy-n63YI3GoM51MPUxhuNyckpnq-scUeUD-lz_snmpb5ewuNepTsFt2QZfW1_rxbo5ot8JfUrZ-i1a9bx6YpRL-OIhXlXfPn64u_7c3Hz99OX6_U2jORG5QUPM1HHeEz5MlIJGNamOMTHyXhgBYiJ66JnqDBVq4pqLcoIYldZzB0pQdlW92fuWxX9umLI82KTROeUxbEkS3tNihI5QUL6jOoaUIhp5jPag4kkSkGejcpW7UXk2KqGTxWgpe_UwYZsOOP8t-qOwAO92AMud9xajTNqi1zjbWKzKOdj_Tfi3gXbWW63cDzxhWsMWfXEoiUxUgrw9f_X8VMIASAeU_QaJm56q</recordid><startdate>20131201</startdate><enddate>20131201</enddate><creator>Izol, Volkan</creator><creator>Aridogan, Ibrahim Atilla</creator><creator>Karsli, Onur</creator><creator>Deger, Mutlu</creator><creator>Satar, Nihat</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20131201</creationdate><title>The effect of prophylactic treatment with Shohl's solution in children with cystinuria</title><author>Izol, Volkan ; Aridogan, Ibrahim Atilla ; Karsli, Onur ; Deger, Mutlu ; Satar, Nihat</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c417t-ef1fb5446148b220ceaba53379467f707b1c863a5f27ab4c4703779accd50a723</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Adolescent</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Children</topic><topic>Citric Acid - therapeutic use</topic><topic>Cystinuria</topic><topic>Cystinuria - drug therapy</topic><topic>Cystinuria - epidemiology</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Humans</topic><topic>Hydrogen-Ion Concentration</topic><topic>Infant</topic><topic>Male</topic><topic>Nephrostomy, Percutaneous</topic><topic>Pediatrics</topic><topic>Potassium Citrate - therapeutic use</topic><topic>Recurrence</topic><topic>Risk Factors</topic><topic>Secondary Prevention</topic><topic>Shohl's solution</topic><topic>Solutions - therapeutic use</topic><topic>Urolithiasis</topic><topic>Urolithiasis - drug therapy</topic><topic>Urolithiasis - epidemiology</topic><topic>Urolithiasis - prevention &amp; control</topic><topic>Urology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Izol, Volkan</creatorcontrib><creatorcontrib>Aridogan, Ibrahim Atilla</creatorcontrib><creatorcontrib>Karsli, Onur</creatorcontrib><creatorcontrib>Deger, Mutlu</creatorcontrib><creatorcontrib>Satar, Nihat</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of pediatric urology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Izol, Volkan</au><au>Aridogan, Ibrahim Atilla</au><au>Karsli, Onur</au><au>Deger, Mutlu</au><au>Satar, Nihat</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The effect of prophylactic treatment with Shohl's solution in children with cystinuria</atitle><jtitle>Journal of pediatric urology</jtitle><addtitle>J Pediatr Urol</addtitle><date>2013-12-01</date><risdate>2013</risdate><volume>9</volume><issue>6</issue><spage>1218</spage><epage>1222</epage><pages>1218-1222</pages><issn>1477-5131</issn><eissn>1873-4898</eissn><abstract>Abstract Objective To investigate the effect of prophylactic treatment with Shohl's solution on the rates of stone recurrence in paediatric patients with cystinuria. Patients and methods Between June 2007 and October 2011, 185 patients aged 16 years and younger whose stones had been completely removed by percutaneous nephrolithotomy (PCNL) were assessed for metabolic risk factors. Seventeen (9%) patients with positive cyanide-nitroprusside tests (CNT) and cystine stones enrolled in this study, and a Shohl's solution was used for alkalinisation. The patients were followed up for a mean period of two years for stone recurrence. Results Of the patients, 10 (59%) were male, and 7 (41%) were female ( p  = 0.13). Twelve patients (70.5%) continued to receive medical prophylaxis regularly, whereas 5 (29.5%) patients did not. The mean pre-treatment and post-treatment urinary pH values were 5.8 ± 0.5 (5–7) and 7.5 ± 0.4 (6.5–8), respectively ( p  &lt; 0.001). The pre-treatment and post-treatment specific gravities of the urine were 1021.5 ± 5.4 (1010–1030) and 1006 ± 2.3 (1004–1015), respectively ( p  &lt; 0.001). The rates of recurrence were 16.6% among those who continued prophylaxis and 100% among those who did not receive prophylaxis ( p  = 0.001). The most common combination of metabolic anomalies was cystinuria and hypocitraturia ( p  &lt; 0.001). Conclusions This study demonstrated that detailed clinical and laboratory evaluations should be performed for all children with cystine stone disease, and, appropriate prophylactic treatment should be recommended to prevent the reformation of stones.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>23806278</pmid><doi>10.1016/j.jpurol.2013.05.017</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1477-5131
ispartof Journal of pediatric urology, 2013-12, Vol.9 (6), p.1218-1222
issn 1477-5131
1873-4898
language eng
recordid cdi_proquest_miscellaneous_1462187290
source ScienceDirect Journals
subjects Adolescent
Child
Child, Preschool
Children
Citric Acid - therapeutic use
Cystinuria
Cystinuria - drug therapy
Cystinuria - epidemiology
Female
Follow-Up Studies
Humans
Hydrogen-Ion Concentration
Infant
Male
Nephrostomy, Percutaneous
Pediatrics
Potassium Citrate - therapeutic use
Recurrence
Risk Factors
Secondary Prevention
Shohl's solution
Solutions - therapeutic use
Urolithiasis
Urolithiasis - drug therapy
Urolithiasis - epidemiology
Urolithiasis - prevention & control
Urology
title The effect of prophylactic treatment with Shohl's solution in children with cystinuria
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T20%3A53%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20effect%20of%20prophylactic%20treatment%20with%20Shohl's%20solution%20in%20children%20with%20cystinuria&rft.jtitle=Journal%20of%20pediatric%20urology&rft.au=Izol,%20Volkan&rft.date=2013-12-01&rft.volume=9&rft.issue=6&rft.spage=1218&rft.epage=1222&rft.pages=1218-1222&rft.issn=1477-5131&rft.eissn=1873-4898&rft_id=info:doi/10.1016/j.jpurol.2013.05.017&rft_dat=%3Cproquest_cross%3E1462187290%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c417t-ef1fb5446148b220ceaba53379467f707b1c863a5f27ab4c4703779accd50a723%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1462187290&rft_id=info:pmid/23806278&rfr_iscdi=true